Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biobucks
Biotech
GSK pays Flagship biotech $80M for preclinical neuro pact
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius.
Gabrielle Masson
Nov 12, 2024 6:30am
AbbVie pays $65M for options on EvolveImmune's T-cell engagers
Oct 31, 2024 10:00am
Biogen buys in to molecular glues with deal worth up to $1.45B
Oct 30, 2024 10:50am
Novartis inks $150M deal for autoimmune molecular glue
Oct 28, 2024 7:00am
Editas prioritizes in vivo therapies, seeks reni-cel partner
Oct 22, 2024 9:39am
Merck signs $1.9B deal to explore fibroblast therapies
Oct 8, 2024 8:55am
